The avian erythroblastosis virus erbA oncogene encodes a DNA-binding protein exhibiting distinct nuclear and cytoplasmic subcellular localizations.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMC 250565)

Published in J Virol on February 01, 1988

Authors

P Boucher1, A Koning, M L Privalsky

Author Affiliations

1: Department of Biochemistry/Biophysics, University of California, Davis 95616.

Articles citing this

An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J Virol (1990) 3.13

Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins. Nucleic Acids Res (1995) 2.52

Splinkerettes--improved vectorettes for greater efficiency in PCR walking. Nucleic Acids Res (1995) 2.51

Xenopus laevis alpha and beta thyroid hormone receptors. Proc Natl Acad Sci U S A (1990) 1.51

Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells. J Virol (1991) 1.26

c-erbA encodes multiple proteins in chicken erythroid cells. Mol Cell Biol (1988) 1.16

Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha. Proc Natl Acad Sci U S A (1993) 1.08

Sequence-specific DNA binding by the v-erbA oncogene protein of avian erythroblastosis virus. J Virol (1990) 0.96

Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function. J Virol (1991) 0.95

Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype. EMBO J (1992) 0.94

The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the protein. Nucleic Acids Res (1990) 0.93

Genetic dissection of functional domains within the avian erythroblastosis virus v-erbA oncogene. Mol Cell Biol (1988) 0.89

A subpopulation of the avian erythroblastosis virus v-erbA protein, a member of the nuclear hormone receptor family, is glycosylated. J Virol (1990) 0.79

Avian erythroblastosis virus transforms a novel mast cell-basophil precursor target in the Japanese quail. J Virol (1989) 0.75

Articles cited by this

Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J (1985) 20.39

Detection and quantification of phosphotyrosine in proteins. Methods Enzymol (1983) 11.89

Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (1986) 11.35

Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet (1985) 10.62

The c-erb-A gene encodes a thyroid hormone receptor. Nature (1987) 10.53

The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature (1987) 7.06

Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J (1987) 5.76

Nuclear location signals in polyoma virus large-T. Cell (1986) 5.74

Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation. Cell (1979) 5.61

The protein encoded by the transforming gene of avian sarcoma virus (pp60src) and a homologous protein in normal cells (pp60proto-src) are associated with the plasma membrane. Proc Natl Acad Sci U S A (1980) 4.99

Sequence and expression of human estrogen receptor complementary DNA. Science (1986) 4.36

Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein. Cell (1985) 4.02

The erbB gene of avian erythroblastosis virus is a member of the src gene family. Cell (1983) 3.82

Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell (1987) 3.62

Nuclear location of the putative transforming protein of avian myelocytomatosis virus. Cell (1982) 3.51

Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement. Nature (1987) 3.42

Continuous and discontinuous protein antigenic determinants. Nature (1986) 3.26

Transforming capacities of avian erythroblastosis virus mutants deleted in the erbA or erbB oncogenes. Cell (1983) 3.03

Defectiveness of avian erythroblastosis virus: synthesis of a 75K gag-related protein. Virology (1979) 2.87

Site-specific mutagenesis of avian erythroblastosis virus: erb-B is required for oncogenicity. Virology (1983) 2.53

Identification and characterization of the avian erythroblastosis virus erbB gene product as a membrane glycoprotein. Cell (1983) 2.44

Hormone-dependent terminal differentiation in vitro of chicken erythroleukemia cells transformed by ts mutants of avian erythroblastosis virus. Cell (1982) 2.33

Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product. Nature (1986) 2.18

Protein phosphorylation at tyrosine is induced by the v-erbB gene product in vivo and in vitro. Cell (1985) 2.16

Sequencing the erbA gene of avian erythroblastosis virus reveals a new type of oncogene. Science (1984) 2.12

Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformation. Cell (1983) 2.08

Virus-specific RNAs in cells infected by avian myelocytomatosis virus and avian erythroblastosis virus: modes of oncogene expression. Cell (1981) 1.67

The product of the avian erythroblastosis virus erbB locus is a glycoprotein. Cell (1983) 1.62

Characterization of the hematopoietic target cells of AEV, MC29 and AMV avian leukemia viruses. Exp Cell Res (1981) 1.57

v-erbA cooperates with sarcoma oncogenes in leukemic cell transformation. Cell (1986) 1.56

gag-Related polypeptides encoded by replication-defective avian oncoviruses. J Virol (1979) 1.48

Expression of the v-erbA oncogene in chicken embryo fibroblasts stimulates their proliferation in vitro and enhances tumor growth in vivo. Cell (1987) 1.46

The atomic mobility component of protein antigenicity. Annu Rev Immunol (1985) 1.40

Site-specific mutagenesis of avian erythroblastosis virus: v-erb-A is not required for transformation of fibroblasts. Virology (1983) 1.40

Proteins specified by avian erythroblastosis virus: coding region localization and identification of a previously undetected erb-B polypeptide. Proc Natl Acad Sci U S A (1982) 1.36

Comparative tryptic peptide mapping studies suggest a role in cell transformation for the gag-related protein of avian erythroblastosis virus and avian myelocytomatosis virus strains CMII and MC29. Proc Natl Acad Sci U S A (1980) 1.31

Molecular cloning of the chicken progesterone receptor. Science (1986) 1.30

In vitro translation of avian erythroblastosis virus RNA: identification of two major polypeptides. Virology (1980) 1.29

The membrane glycoprotein encoded by the retroviral oncogene v-erb-B is structurally related to tyrosine-specific protein kinases. Proc Natl Acad Sci U S A (1984) 1.23

Cell-free translation of avian erythroblastosis virus RNA yields two specific and distinct proteins with molecular weights of 75,000 and 40,000. Virology (1980) 1.21

Target cells infected by avian erythroblastosis virus differentiate and become transformed. Cell (1982) 1.21

Subcellular localization of the v-erb-B protein, the product of a transforming gene of avian erythroblastosis virus. Virology (1984) 1.20

Cell-free translation of avian erythroblastosis virus RNA. J Virol (1980) 1.20

Rous-associated virus 1-induced erythroleukemic cells exhibit a weakly transformed phenotype in vitro and release c-erbB-containing retroviruses unable to transform fibroblasts. J Virol (1986) 1.16

Structural domains of the avian erythroblastosis virus erbB protein required for fibroblast transformation: dissection by in-frame insertional mutagenesis. J Virol (1986) 1.07

Avian erythroblastosis virus produces two mRNA's. J Virol (1980) 1.04

Production and characterization of antisera specific for the erb-portion of p75, the presumptive transforming protein of avian erythroblastosis virus. Virology (1981) 1.03

Chromatin receptors for thyroid hormones. Interactions of the solubilized proteins with DNA. J Biol Chem (1976) 0.92

Orientation of the v-erb-B gene product in the plasma membrane. Mol Cell Biol (1986) 0.90

Biochemical characterization of transformation-specific proteins of acute avian leukemia and sarcoma viruses. J Cell Biochem (1982) 0.86

Steroid receptors: oncogenes as hormone receptors. Nature (1986) 0.79

Articles by these authors

Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell (1997) 8.72

SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1997) 2.75

Site-specific mutagenesis of avian erythroblastosis virus: erb-B is required for oncogenicity. Virology (1983) 2.53

Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol Endocrinol (1996) 2.02

The product of the avian erythroblastosis virus erbB locus is a glycoprotein. Cell (1983) 1.62

Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6. J Biol Chem (1998) 1.61

The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol Cell Biol (2000) 1.60

Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol Endocrinol (1997) 1.60

In vivo examination of membrane protein localization and degradation with green fluorescent protein. Proc Natl Acad Sci U S A (1996) 1.59

Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB. Mol Cell Biol (1998) 1.51

Proteins specified by avian erythroblastosis virus: coding region localization and identification of a previously undetected erb-B polypeptide. Proc Natl Acad Sci U S A (1982) 1.36

The structure and synthesis of influenza virus phosphoproteins. J Biol Chem (1981) 1.27

Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs. Oncogene (2006) 1.26

Phosphorylated protein component present in influenza virions. J Virol (1977) 1.24

The membrane glycoprotein encoded by the retroviral oncogene v-erb-B is structurally related to tyrosine-specific protein kinases. Proc Natl Acad Sci U S A (1984) 1.23

Subcellular localization of the v-erb-B protein, the product of a transforming gene of avian erythroblastosis virus. Virology (1984) 1.20

Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors. Mol Cell Biol (1998) 1.16

Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable. Blood (2000) 1.15

Reconstitution of retinoid X receptor function and combinatorial regulation of other nuclear hormone receptors in the yeast Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1993) 1.13

v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action. Cell (1991) 1.11

Nuclear hormone receptors involved in neoplasia: erb A exhibits a novel DNA sequence specificity determined by amino acids outside of the zinc-finger domain. Mol Cell Biol (1993) 1.08

Influenza virus proteins: identity, synthesis, and modification analyzed by two-dimensional gel electrophoresis. Proc Natl Acad Sci U S A (1978) 1.08

Structural domains of the avian erythroblastosis virus erbB protein required for fibroblast transformation: dissection by in-frame insertional mutagenesis. J Virol (1986) 1.07

Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients. Leukemia (2009) 1.06

Cooperative formation of high-order oligomers by retinoid X receptors: an unexpected mode of DNA recognition. Proc Natl Acad Sci U S A (1995) 1.05

The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms. Mol Cell Biol (1993) 1.04

Transcriptional anti-repression. Thyroid hormone receptor beta-2 recruits SMRT corepressor but interferes with subsequent assembly of a functional corepressor complex. J Biol Chem (1999) 1.02

A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release. Mol Cell Biol (1997) 1.02

Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor. Mol Endocrinol (1998) 1.00

v-erbA and citral reduce the teratogenic effects of all-trans retinoic acid and retinol, respectively, in Xenopus embryogenesis. Development (1993) 0.99

DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia. Cell Growth Differ (2001) 0.99

Transmembrane domain of the AEV erb B oncogene protein is not required for partial manifestation of the transformed phenotype. Virology (1987) 0.97

Plasticity of tetramer formation by retinoid X receptors. An alternative paradigm for DNA recognition. J Biol Chem (1997) 0.97

Sequence-specific DNA binding by the v-erbA oncogene protein of avian erythroblastosis virus. J Virol (1990) 0.96

DNA recognition by normal and oncogenic thyroid hormone receptors. Unexpected diversity in half-site specificity controlled by non-zinc-finger determinants. J Biol Chem (1996) 0.95

Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with Its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemia. Mol Cell Biol (2001) 0.95

Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function. J Virol (1991) 0.95

V-erbA and c-erbA proteins enhance transcriptional activation by c-jun. Oncogene (1992) 0.94

The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II). Mol Cell Biochem (2001) 0.94

Transcriptional repression by thyroid hormone receptors. A role for receptor homodimers in the recruitment of SMRT corepressor. J Biol Chem (2001) 0.93

Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor. Mol Cell Endocrinol (2000) 0.93

Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire. Oncogene (2009) 0.91

Orientation of the v-erb-B gene product in the plasma membrane. Mol Cell Biol (1986) 0.90

Genetic dissection of functional domains within the avian erythroblastosis virus v-erbA oncogene. Mol Cell Biol (1988) 0.89

Mapping of functional domains within the v-erb A oncogene protein: the remnants of the hormone binding domain play multiple, vital roles in protein action. Oncogene (1990) 0.86

Phosphorylation of thyroid hormone receptors by protein kinase A regulates DNA recognition by specific inhibition of receptor monomer binding. J Biol Chem (1998) 0.86

Patchwork access. Primary care in EDs on the rise. Hospitals (1993) 0.85

Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia. Leukemia (2012) 0.84

Mutagenesis of the avian erythroblastosis virus erbB coding region: an intact extracellular domain is not required for oncogenic transformation. J Virol (1986) 0.83

Creation of a chimeric oncogene: analysis of the biochemical and biological properties of v-erbB/src fusion polypeptide. J Virol (1987) 0.83

Isoform-specific transcriptional regulation by thyroid hormone receptors: hormone-independent activation operates through a steroid receptor mode of co-activator interaction. Mol Endocrinol (2001) 0.83

Functional domains of the v-erbA protein necessary for oncogenesis are required for transcriptional activation in Saccharomyces cerevisiae. Oncogene (1993) 0.82

Reconstitution of thyroid hormone receptor and retinoic acid receptor function in the fission yeast Schizosaccharomyces pombe. Mol Endocrinol (1994) 0.80

DNA sequence specificity of the v-erb A oncoprotein/thyroid hormone receptor: role of the P-box and its interaction with more N-terminal determinants of DNA recognition. Mol Endocrinol (1994) 0.80

Retinoid X and retinoic acid receptors interact with transcription factor II-B by distinct mechanisms. Mol Cell Endocrinol (1997) 0.79

Role of the N terminus in DNA recognition by the v-erb A protein, an oncogenic derivative of a thyroid hormone receptor. Mol Endocrinol (1995) 0.77

Retinoid isomers differ in the ability to induce release of SMRT corepressor from retinoic acid receptor-alpha. J Biol Chem (1999) 0.77

[Fiber in enteral nutrition: systematic review of the literature]. Nutr Hosp (2004) 0.76

Functional interaction between the two zinc finger domains of the v-erb A oncoprotein. Cell Growth Differ (1992) 0.76

[Pharmacy in Dutch political caricature]. Pharm Acta Helv (1979) 0.75

[Complications of enteral nutrition at home. Results of a multicentre trial]. Nutr Hosp (2003) 0.75

[Nutritional management of radiation-induced enteritis: apropos of a case]. Nutr Hosp (1999) 0.75

[Critical analysis of the evolution of commercial preparations for enteral nutrition during 1988-1996]. Nutr Hosp (1999) 0.75